AllianceBernstein’s Aceragen Inc ACGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-1,032
Closed -$49K 3144
2018
Q4
$49K Hold
1,032
﹤0.01% 3061
2018
Q3
$156K Buy
1,032
+224
+28% +$32K ﹤0.01% 3030
2018
Q2
$145K Buy
808
+215
+36% +$50.2K ﹤0.01% 3024
2018
Q1
$148K Buy
593
+194
+49% +$53.2K ﹤0.01% 2920
2017
Q4
$114K Sell
399
-199
-33% -$56.8K ﹤0.01% 2948
2017
Q3
$181K Sell
598
-64
-10% -$16.7K ﹤0.01% 2967
2017
Q2
$155K Buy
662
+93
+16% +$24.3K ﹤0.01% 3050
2017
Q1
$191K Hold
569
﹤0.01% 2863
2016
Q4
$116K Buy
569
+109
+24% +$26K ﹤0.01% 2961
2016
Q3
$160K Sell
460
-30
-6% -$7.94K ﹤0.01% 2888
2016
Q2
$102K Buy
490
+81
+20% +$17.9K ﹤0.01% 2908
2016
Q1
$110K Hold
409
﹤0.01% 2809
2015
Q4
$172K Hold
409
﹤0.01% 2782
2015
Q3
$186K Hold
409
﹤0.01% 2798
2015
Q2
$206K Buy
409
+118
+41% +$54.2K ﹤0.01% 2870
2015
Q1
$147K Buy
291
+83
+40% +$50.6K ﹤0.01% 2932
2014
Q4
$125K Sell
208
-44
-17% -$17.6K ﹤0.01% 2940
2014
Q3
$78K Hold
252
﹤0.01% 3013
2014
Q2
$99K Buy
252
+245
+3,500% +$101K ﹤0.01% 2998
2014
Q1
$4K Hold
7
﹤0.01% 3354
2013
Q4
$4K Hold
7
﹤0.01% 3174
2013
Q3
$2K Buy
+7
New +$1.4K ﹤0.01% 3283

Other funds holding ACGN

AllianceBernstein's ACGN Position: Q1 2019 in Review

AllianceBernstein sold out of Aceragen Inc (ACGN) in Q1 2019, closing a stake of 1,032 shares — an estimated $49K sold.

AllianceBernstein first reported a position in ACGN in Q3 2013 and held it in 22 quarters. The position peaked at $206K in Q2 2015. 69 funds tracked by Wall St. Rank hold ACGN as of Q1 2019.

  • AllianceBernstein reported no remaining Aceragen Inc position as of Q1 2019 after selling out during the quarter.
  • AllianceBernstein sold 1,032 Aceragen Inc shares in Q1 2019, an estimated $49K.
  • AllianceBernstein first reported a position in Aceragen Inc in Q3 2013 and held it in 22 quarters.
  • AllianceBernstein's Aceragen Inc position peaked at $206K in Q2 2015.
  • 69 funds tracked by Wall St. Rank held Aceragen Inc as of Q1 2019.

Based on AllianceBernstein's 13F filing for Q1 2019, filed 14 May 2019.